Related Experiment Video
Updated: May 28, 2026

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
Published on: June 7, 2017
Smac mimetics and TNFalpha: a dangerous liaison?
Hao Wu1, Jurg Tschopp, Su-Chang Lin
1Department of Biochemistry, Weill Medical College of Cornell University, New York, NY 10021, USA. haowu@med.cornell.edu
Abstract:
Inhibitor of apoptosis proteins (IAPs) such as XIAP, cIAP1, and cIAP2 are upregulated in many cancer cells. It has been thought that small-molecule mimetics of Smac, an endogenous IAP antagonist, might potentiate apoptosis in cancer cells by promoting caspase activation. However, three recent papers, two in Cell (Vince et al., 2007; Varfolomeev et al., 2007) and one in Cancer Cell (Petersen et al., 2007), now report that Smac mimetics primarily kill cancer cells via a different mechanism, the induction of autoubiquitination and degradation of cIAPs, which culminates in TNFalpha-mediated cell death.
Insights
Small-molecule Smac mimetics kill cancer cells by inducing self-degradation of inhibitor of apoptosis proteins (IAPs). This process leads to tumor necrosis factor-alpha (TNFα)-mediated cell death, revealing a novel therapeutic mechanism.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Pathways
Background:
- Inhibitor of apoptosis proteins (IAPs) like XIAP, cIAP1, and cIAP2 are frequently overexpressed in cancer cells.
- IAPs play a crucial role in preventing programmed cell death (apoptosis).
- Small-molecule Smac mimetics were hypothesized to enhance apoptosis by promoting caspase activation.
Purpose of the Study:
- To investigate the precise mechanism by which Smac mimetics induce cancer cell death.
- To elucidate the role of IAPs in the cellular response to Smac mimetics.
- To identify alternative pathways for cancer therapy targeting IAPs.
Main Methods:
- Utilized Smac mimetic compounds in cancer cell models.
- Analyzed protein degradation pathways, focusing on cIAPs.
- Investigated the involvement of TNFα signaling in cell death induction.
Main Results:
- Smac mimetics primarily induce autoubiquitination and subsequent degradation of cIAP1 and cIAP2.
- This degradation event is the main driver of cancer cell death, not direct caspase activation.
- The process culminates in TNFα-mediated necroptosis, a form of inflammatory cell death.
Conclusions:
- Smac mimetics represent a novel class of anti-cancer agents targeting IAP degradation.
- The primary mechanism involves cIAP depletion, leading to TNFα-induced cell death.
- These findings offer new therapeutic strategies for cancers with upregulated IAPs.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...

